Sep 30, 2013 ... Research like the Zelboraf tests, that fine-tune treatments to the genetic profile of
patients, is fuelling a rethink over how new cancer drugs are ...
www.focr.org/sites/default/files/Immunotx final 11 4.pdf
Renzo Canetta, Vice President, Oncology Global Clinical Research, Bristol-
Myers Squibb ..... Insight: How new cancer drugs can skip randomized trials.
We can also do better by doing research on combinations of new and .....
Steenhuysen J, Hirschler B. Insight: How new cancer drugs can skip randomized
Oct 23, 2012 ... Skip to main content; Skip to navigation; Resources · How To · About NCBI
Accesskeys ... Keywords: cancer, personalized medicine, N-of-1, omics,
longitudinal ... (NGS) has already yielded profound new insights into cancer
biology. ... However, randomized trials can encounter difficulty in the face of ...
May 2, 2014 ... Skip to main content; Skip to navigation; Resources · How To · About NCBI
Accesskeys ... The choice of OS as a primary endpoint for clinical trials could not
be ... Although randomized clinical trials are recognized as the highest level of ...
In recent years, several new drugs have been proposed for MBC, b...
Apr 11, 2016 ... FDA and Clinical Drug Trials: A Short History: article by Suzanne White Junod,
Ph.D. ... In the future, FDA could use these new tools not only to ban Banbar, but
to ... products submitted for approval to treat serious diseases (i.e. cancer ....
Although several kinds of randomized controlled trial methodologies ...
Gene Tests Identify Breast Cancer Patients Who Can Skip .... Dr. Ian Krop led a
study identifying a new breast cancer treatment .... Dr. Harold Burstein provided
insight to dispel the myth that antiperspirants cause breast cancer. .... of Medicine
, that consisted of four phase 3 randomized trials in ...
Feb 9, 2015 ... Skip to content ... New Experimental Breast Cancer Drug Shows Promise ... a trial
of 165 women with ER-positive advanced breast cancer who had not ...
randomized phase II study and full approval will depend on results of a ...
Oct 21, 2016 ... Skip to content ... Keytruda is one of a new class of immunotherapy drugs known
as ... In the KEYNOTE-045 trial, the patients were randomized to receive ...
Further details of the results will be presented at scientific meetings and
published in journals. ... Email the editors at email@example.com.
New drug beats standard therapy in advanced kidney cancer (November 14,
2016) ... of a randomized phase II clinical trial by researchers at Dana-Farber
Cancer .... Surgery can lengthen survival of metastatic kidney cancer patients
treated ..... This insight could open new avenues for preventing and treating